BioPharm International, May 2022 Issue

Emerging Plant-based Platform for Biomanufacturing

May 02, 2022

Feature

35

5

Plant-based manufacturing technology gains mainstream edge in biopharmaceutical production.

Dual Modality and New Analyses

May 01, 2022

From the Editor

35

5

Fresh insight is instrumental in the discussion of novel analytics.

Which Batch Size for Validation and Stability Studies?

May 01, 2022

Ask The Expert

35

5

Process validation for a drug product must be done with commercial scale batches, says Siegfried Schmitt, vice president, Technical at Parexel.

Back to INTERPHEX

May 01, 2022

From the CEO

35

5

Spring has returned, and with it comes INTERPHEX.